Published: May 2013 | Pages: 79
Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report estimated that prevalence of asthma in the general population varied widely in different countries around the world, with proportions ranging between 1% in Albania and 18% in Wales (Masoli et al., 2004; WHO, 2007). Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment (Masoli et al., 2004; WHO, 2007).
GlobalData epidemiologists predict a substantial increase in the number of lifetime prevalent cases of asthma in the 10 major markets during the forecast period. GlobalData epidemiologists forecast that there will be approximately 159.20 million lifetime prevalent cases of asthma in the 10 major markets by 2022, with an overall growth of 17.7% over the next decade. GlobalData epidemiologists attribute the projected increase in the lifetime prevalent cases of asthma across all the markets covered in this analysis to changing population demographics in the respective markets, except for the US and the UK, where this growth is also attributed to trends in genetic determinants, social status, environmental factors, and changes in policies related to disease identification and recording (Simpson and Sheikh, 2010; Smith et al., 2005).
- The asthma EpiCast Report provides overview of the risk factors and global trends for asthma in the 10 major markets (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India).
- In addition, the report includes a 10-year epidemiological forecast of the lifetime prevalent cases of asthma segmented by sex, age (in five-year increments beginning at 0 years and ending at ages 85 years and older), and asthma severity in these 10 markets.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global asthma market.
- Quantify patient populations in the global asthma market to improve product development, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex, age groups, and disease severity groups that present the best opportunities for asthma therapeutics in each of the markets covered.
1 Table of Contents 41.1 List of Tables 61.2 List of Figures 72 Introduction 82.1 Catalyst 82.2 Upcoming Reports 83 Epidemiology 93.1 Disease Background 93.2 Risk Factors and Comorbidities 103.2.1 Family history of asthma is a strong predictor for asthma in children and adults 113.2.2 Puberty alters the risk for asthma in boys and girls 123.2.3 Maternal smoking during pregnancy increases the risk of childhood asthma by almost 70% 133.2.4 Allergens are well-known asthma triggers 143.2.5 Common workplace exposures account for up to 11% of asthma cases in adults 153.2.6 Urban living conditions, not race, increase the risk of asthma by almost 50% 163.2.7 Obesity almost triples the risk of developing asthma 173.2.8 Asthmatics are 90% more likely to develop GERD 183.2.9 85% of asthmatics have allergic rhinitis 193.2.10 Panic disorders are common in asthmatics and severely impact disease control 203.2.11 Thirty-nine percent of asthmatics are likely to develop depression 213.3 Global Trends 213.3.1 US 223.3.2 France 243.3.3 Germany 253.3.4 Italy 253.3.5 Spain 263.3.6 UK 273.3.7 Japan 283.3.8 Australia 293.3.9 China 293.3.10 India 303.4 Forecast Methodology 323.4.1 Sources Used 333.4.2 Forecast Assumptions and Methods 443.4.3 Sources Not Used 513.5 Epidemiology Forecast for Asthma (2012–2022) 513.5.1 Lifetime Prevalent Cases of Asthma 513.5.2 Age-Specific Lifetime Prevalent Cases of Asthma 533.5.3 Sex-Specific Lifetime Prevalent Cases of Asthma 553.5.4 Age-Standardized Lifetime Prevalence of Asthma 573.5.5 Distribution of Lifetime Prevalent Cases of Asthma by Severity 583.6 Discussion 613.6.1 Conclusions on Epidemiology Trends 613.6.2 Limitations of the Analysis 633.6.3 Strengths of the Analysis 644 Appendix 654.1 Bibliography 654.2 About the Authors 754.2.1 Epidemiologists 754.2.2 Reviewers 754.2.3 Global Director of Epidemiology and Clinical Trials Analysis 774.2.4 Global Head of Healthcare 774.3 About GlobalData 784.4 About EpiCast 784.5 Contact Us 794.6 Disclaimer 79List of TablesTable 1: GINA Guidelines for Classification of Asthma by Severity 9Table 2: Risk Factors and Comorbidities of Asthma 10Table 3: Lifetime Prevalence (%) of Asthma by Race in the US, All Ages, Both Sexes, 2001–2011 23Table 4: Trends in the Prevalence (%) of Self-reported Asthma in Children in Spain 26Table 5: Trends in the Lifetime Prevalence (%) of Asthma in the UK 27Table 6: Lifetime Prevalence (%) of Asthma in Children in China 30Table 7: Prevalence (%) of Asthma in Children and Adults in India 31Table 8: Questions Asked to Assess Lifetime Asthma Prevalence 32Table 9: All Markets, Epidemiological Sources of Lifetime Asthma Prevalence Data 33Table 10: All Markets, Epidemiological Sources of Asthma Severity Data 34Table 11: Overview of the Ellis Criteria for Childhood Asthma Severity Classification 43Table 12: All Markets, Lifetime Prevalent Cases of Asthma, All Ages, Men and Women, N (Millions), 2012–2022 52Table 13: All Markets, Lifetime Prevalent Cases of Asthma, by Age, N (Millions), (Row %), 2012 54Table 14: All Markets, Lifetime Prevalent Cases of Asthma, by Sex, All Ages, N (Row %), 2012 56Table 15: All Markets, Lifetime Prevalent Cases of Asthma by Severity, All Ages, Men and Women, N (Row %), 2012 59List of FiguresFigure 1: Lifetime Prevalence (%) of Asthma by Race in the US, All Ages, Both Sexes, 2001–2011 23Figure 2: All Markets, Lifetime Prevalent Cases of Asthma, All Ages, Men and Women, N (Millions), 2012–2022 53Figure 3: All Markets, Lifetime Prevalent Cases of Asthma, by Age, N (Millions), 2012 55Figure 4: All Markets, Lifetime Prevalent Cases of Asthma, by Sex, N (Millions), 2012 57Figure 5: All Markets, Age-Standardized Lifetime Prevalence of Asthma, All Ages, Men and Women, %, 2012 58
Figure 6: All Markets, Lifetime Prevalent Cases of Asthma by Severity, All Ages, Men and Women, N (Millions), 2012 60